metformin and phosphothreonine

metformin has been researched along with phosphothreonine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Attar, N; Comin-Anduix, B; Glaspy, JA; Guo, D; Lo, RS; Matsunaga, D; Mischel, PS; Ng, C; Niehr, F; Recio, JA; Ribas, A; Sazegar, H; von Euw, E	1

Other Studies

1 other study(ies) available for metformin and phosphothreonine

Article	Year
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations. Journal of translational medicine, 2011, May-24, Volume: 9 Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Culture Media; DNA Mutational Analysis; Drug Synergism; Flow Cytometry; Glucose; Humans; Indoles; Melanoma; Metformin; Mutation; Phosphorylation; Phosphothreonine; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonamides; Time Factors; Vemurafenib	2011

Article

Year

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations.

Journal of translational medicine, 2011, May-24, Volume: 9

Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Culture Media; DNA Mutational Analysis; Drug Synergism; Flow Cytometry; Glucose; Humans; Indoles; Melanoma; Metformin; Mutation; Phosphorylation; Phosphothreonine; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonamides; Time Factors; Vemurafenib

2011